Cannabix Technologies Inc. (OTC: BLOZF) (CSE:BLO), developer of the patent pending Cannabix Marijuana Breathalyzer™ for law enforcement, recently announced that it would be attending the 3rd annual Marijuana Business Conference and Expo on November 12th through the 14th in Las Vegas, Nevada.
As the largest and oldest national trade show for the legal cannabis and medical marijuana industry, the Marijuana Business Conference and Expo attracts attendees from more than 30 states and 10 countries. The conference will feature 60 expert speakers with over 125 exhibits that will cover every part of the growing industry.
“We look forward to attending this sold out conference and marketing Cannabix to industry professionals,” said Cannabix Technologies Inc. President Kal Malhi. “We are seeing increasing interest in our device and ramping up in national attention on the marijuana industry as Alaska, Oregon, Washington D.C., and Florida will look to vote on legalization of marijuana in their respective states in November.”
Cannabix Technologies will be presenting its drug-impairment recognition system, known as the Cannabix Marijuana Breathalyzer™, which is based on breath testing technology that has been developed in Sweden. In early clinical research, the technology was shown to be successful in testing individuals for recent consumption of the Tetrahydrocannabinol (“THC”) component of marijuana.
“Cannabix is progressing well on its prototype development of its marijuana breathalyzer,” added Mr. Malhi. CThe company and its engineering contractor KLN Klein are designing a feature rich hand-held device for law enforcement. Development has been systematically moving forward with electronics hardware, circuit board development, software development, and procurement of parts for assembly of the first prototype unit.”
The technology will enable law enforcement personnel to enhance detection of marijuana impaired driving offenses on North American roads at a time when marijuana is becoming legal in various jurisdictions. In addition to these markets, management predicts a number of other practical applications, such as testing employees in the workplace where intoxication can be dangerous.
Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.